Statement on the fourth meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of coronavirus disease (COVID-19) – World Health Organization

Share finest practices, consisting of from intra-action reviews, with WHO; use lessons gained from nations that are effectively re-opening their societies (consisting of businesses, schools, and other services) and mitigating renewal of COVID-19.
Support multilateral local and international organizations and motivate global solidarity in COVID-19 response.
Enhance and sustain political dedication and leadership for nationwide methods and localized reaction activities driven by science, data, and experience; engage all sectors in attending to the impacts of the pandemic.
Continue to improve capacity for public health monitoring, screening, and contact tracing..
Share prompt info and data with WHO on COVID-19 epidemiology and intensity, action steps, and on concurrent illness break outs through platforms such as the Global Influenza Surveillance and Response System.
Enhance neighborhood engagement, empower people, and develop trust by attending to mis/disinformation and providing clear assistance, reasonings, and resources for public health and social procedures to be accepted and carried out.
Take part in the Access to COVID-19 Tools (ACT) Accelerator, participate in pertinent trials, and get ready for effective and safe healing and vaccine intro.
Implement, frequently update, and share information with WHO on in proportion and proper travel procedures and recommendations, based on risk assessments; execute essential capabilities, including at points of entry, to alleviate the prospective threats of international.
transmission of COVID-19 and to assist in international contact tracing.
Preserve vital health services with adequate funding, products, and human resources; prepare health systems to handle seasonal influenza, other concurrent disease outbreaks, and natural catastrophes.

The 4th conference of the Emergency Committee assembled by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the coronavirus illness (COVID-19) occurred on Friday, 31 July 2020 from 12:00 to 17:45.
Geneva time (CEST)..
Proceedings of the conference.
Members and consultants of the Emergency Committee were assembled by videoconference.
The Director-General invited the Committee, highlighted the advances in worldwide understanding of the SARS-CoV-2 virus because the statement of the general public health emergency of worldwide issue (PHEIC) on 30 January 2020, and detailed key areas where.
even more attention by the Emergency Committees is required.
Agents of the legal department and the Department of Compliance, Risk Management, and Ethics (CRE) briefed the members on their duties and functions. The Ethics Officer from CRE supplied the members and advisers with an overview of the.
WHO Declaration of Interest procedure. The members and advisors were warned of their specific responsibility to reveal to WHO, in a timely manner, any interests of an individual, professional, monetary, intellectual or business nature that may.
trigger a perceived or direct conflict of interest. They were in addition reminded of their duty to keep the confidentiality of the meeting conversations and the work of the committee. Each member who was present was surveyed and no disputes.
of interest were identified.
The Secretariat turned the meeting over to the Chair, Professor Didier Houssin. Teacher Houssin also welcomed the Committee and examined the objectives and agenda of the conference..
The WHO Regional Emergency Directors and the Executive Director of the WHO Health Emergencies Programme (WHE) supplied local and the global scenario overview. WHO continues to assess the international danger level of COVID-19 to be very high. Dr David Heymann,.
chair of the WHE Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH), presented on nationwide best practices and worldwide COVID-19 experiences. Dr Johanna Jordaan presented an introduction of the International Civil Aviation Organization.
( ICAO) Council Aviation Recovery Taskforce (CART)s report and public health focused suggestions..
The Committee expressed gratitude for WHO and partners COVID-19 pandemic reaction efforts. The Committee noted development made on the Temporary Recommendations released on 1 May 2020 and examined extra locations that require further attention.
The Committee highlighted the expected lengthy duration of this COVID-19 pandemic, keeping in mind the significance of continual community, nationwide, regional, and international action efforts.
The Committee motivated all people, in specific young people, and communities to continue to play an active role in avoiding and managing transmission of COVID-19. The Committee acknowledged that State Parties need to enable and support neighborhoods.
and individuals and thus build trust in federal governments reaction measures..
After taking place discussion, the Committee all concurred that the pandemic still makes up a public health emergency of worldwide issue and provided advice to the Director-General.
The Director-General stated that the outbreak of COVID-19 continues to constitute a PHEIC. He accepted the recommendations of the Committee to WHO and released the Committees suggestions to States Parties as Temporary Recommendations under the IHR (2005 )..
The Emergency Committee will be reconvened within three months, at the discretion of the Director-General. The Director-General thanked the Committee for its work.
Guidance to the WHO Secretariat.

Temporary recommendations to State Parties.

They were in addition reminded of their responsibility to preserve the confidentiality of the meeting discussions and the work of the committee. Each member who was present was surveyed and no conflicts.
The WHO Regional Emergency Directors and the Executive Director of the WHO Health Emergencies Programme (WHE) supplied regional and the worldwide situation overview. WHO continues to evaluate the global threat level of COVID-19 to be really high. Dr David Heymann,.

Continue to distill and rapidly interact lessons discovered and best practices from the COVID-19 pandemic and nationwide intra-action evaluations.
Continue to coordinate and set in motion international and regional multilateral organizations, partners and networks for robust political dedication and resourcing of COVID-19 pandemic preparedness and response, consisting of for development of vaccines and therapies.
Supply nuanced, pragmatic assistance on requirements for appropriate COVID-19 response activities to decrease the threat of reaction fatigue in the context of socio-economic pressures.
Continue to support State Parties and partners in conducting active and community-based COVID-19 surveillance, through technical and operational resources, such as guidance, tools, and trainings on case definitions and recognition, contact tracing,.
and death certifications; motivate State Parties to continue reporting pertinent information to WHO through platforms such as the Global Influenza and Surveillance Response System.
Accelerate research study into staying SARS-CoV-2 vital unknowns, such as the animal source and possible animal reservoirs, and enhance understanding of the epidemiology and intensity of COVID-19 (including its long-lasting health impacts; viral characteristics.
such as modes of transmission, shedding, potential anomalies; immunity and associates of protection; co-infection; along with danger aspects and vulnerabilities) and the efficiency of public health procedures.
Continue to deal with partners to counter mis/disinformation and infodemics by establishing and disseminating clear, tailored messaging on the COVID-19 pandemic and its results; motivate and support people and communities to follow suggested.
public health and social measures.
Support diagnostics, effective and safe rehabs and vaccines quick and transparent advancement (including in establishing countries) and equitable access through the Access to COVID-19 Tools (ACT) Accelerator; support all nations to carry out.
the needed medical trials and to get ready for the rollout of rehabs and vaccines.
Deal with partners to modify WHOs travel health guidance to enhance evidence-informed steps consistent with the arrangements of the IHR (2005) to avoid unnecessary disturbance with worldwide travel; proactively and frequently share details.
on travel steps to support State Parties decision-making for resuming international travel.
Assistance State Parties, particularly susceptible nations, in reinforcing their vital health services and accompanying supply chains as well as getting ready for and responding to concurrent outbreaks, such as seasonal influenza.